Diltiazem Dosing for IV and Oral Administration in Emergency Settings
For rapid heart rate control in emergency settings, intravenous diltiazem should be administered as a 0.25 mg/kg bolus over 2 minutes (approximately 15-20 mg for an average adult), followed by either a continuous infusion of 5-15 mg/hour or transition to oral therapy. 1, 2
Intravenous Diltiazem Administration
Initial IV Bolus
- Administer 0.25 mg/kg (approximately 15-20 mg for an average adult) over 2 minutes 1, 2
- For paroxysmal supraventricular tachycardia (PSVT), doses of 0.15-0.25 mg/kg are effective and safe 3
- Onset of action occurs within 2-7 minutes 1
- Lower doses (≤0.2 mg/kg) may be considered to reduce the risk of hypotension while maintaining efficacy 4
IV Continuous Infusion
- Following the initial bolus, start infusion at 5-15 mg/hour 1, 2
- Titrate based on heart rate response and blood pressure 2
- Maximum infusion rate typically does not exceed 15 mg/hour 1
- The median effective infusion rate is approximately 10 mg/hour 5
Transition to Oral Diltiazem
Oral Immediate-Release Dosing
- Initial oral dose: 30 mg (typical starting dose) 6
- Can be administered as soon as 4 hours after IV bolus 5
- May be given as 30-60 mg every 6-8 hours 1
- Studies show oral immediate-release diltiazem may be associated with lower treatment failure rates compared to continuous IV infusion 6
Oral Extended-Release Dosing
- For long-term maintenance: 120-360 mg daily in divided doses or as a single dose with extended-release formulations 1, 7
- Median effective dose of oral extended-release diltiazem is 300 mg daily 5
- Maximum daily oral dose is 360 mg 1, 7
Hybrid Protocol (IV Bolus + Oral Maintenance)
- Administer IV bolus (0.25 mg/kg) followed by oral diltiazem instead of continuous infusion 8
- Discontinue IV infusion approximately 4 hours after first oral dose 5
- This approach shows similar efficacy to traditional IV bolus plus infusion protocols 8
- Particularly useful during IV diltiazem shortages 8
Monitoring and Precautions
Contraindications
- Avoid in patients with heart failure or impaired ventricular function (LVEF <40%) 1, 2
- Contraindicated in pre-excited atrial fibrillation or flutter (WPW syndrome) 1, 9
- Avoid in patients with AV block greater than first degree without a pacemaker 7
- Use with caution in combination with beta-blockers due to risk of bradyarrhythmias 7
Side Effects to Monitor
- Hypotension is the most common adverse effect (18-42% depending on dose) 4
- Risk of hypotension increases with higher doses 4
- Bradycardia may occur, especially with concomitant use of other negative chronotropic agents 9
- Potential worsening of heart failure in predisposed patients 9
Clinical Pearls
- Have resuscitation equipment available during IV administration 9
- For severe bradycardia, consider atropine or temporary pacing 9
- Synchronized cardioversion is preferred over medication in hemodynamically unstable patients 9
- The pharmacokinetics of diltiazem are nonlinear at higher infusion rates, with decreased clearance as doses increase 10
This evidence-based approach to diltiazem dosing in emergency settings provides a structured protocol for both IV and oral administration while highlighting important monitoring parameters and precautions to ensure safe and effective treatment.